MedTrace Logo

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres

NCT02689193 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2020-02-18

No results posted yet for this study

Summary

The IDIS study aims to develop a new rapid diagnostic test for invasive salmonellosis using samples (blood, urine) collected from patients with fever and healthy controls at the Institute of Tropical Medicine (ITM) and collaborating centers. The samples are collected after informed consent and/or assent is given by the participant and are stored in a -80 ⁰C freezer after processing (centrifugation and/or aliquoting). Basic information regarding the patient and the samples are coded and stored in a protected Microsoft Access database. The samples will be shipped to Belgium for proteomic analysis. Identification of Salmonella specific proteins in the samples will hopefully support the development of a rapid diagnostic test. Once this test has been developed, the samples will also be used for validation and evaluation of this test.

Conditions

Interventions

OTHER

Blood sampling

Blood sampling (Volume depending on age, minimum 2.0 ml, maximum 10.9 ml extra)

Sponsors & Collaborators

  • Sihanouk Hospital Center of HOPE

    collaborator OTHER

  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

    collaborator OTHER

  • Vlaams Instituut voor Biotechnologie

    collaborator UNKNOWN

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Laura Kuijpers, MD, MSc · Institute of Tropical Medicine, Antwerp, Belgium

  • Panha Chung · Sihanouk Hospital Center of HOPE (SHCH), Phnom Penh, Cambodia

  • Ange Landela, MD · Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

Eligibility

Min Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Belgium
  • Cambodia
  • Democratic Republic of the Congo

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689193 on ClinicalTrials.gov